FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/092037 [Registered on: 30/07/2025] Trial Registered Prospectively
Last Modified On: 30/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Effectiveness of Homoeopathic Medicines in cases of Cutaneous Lichen Planus 
Scientific Title of Study   Effectiveness Of Individualized Homoeopathic Medicine In Management Of Cutaneous Lichen Planus - A Non- Controlled Experimental Study.  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kalika Adhikrao Devakate 
Designation  MD (Homoeopath) PhD Scholar 
Affiliation  Dr. G. D. Pol Foundation, Y. M. T. Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai 
Address  K. E. S. Chandrakant Hari Keluskar Homoeopathic Medical College and Hospital, Khandala - Alibag, Raigad

Raigarh
MAHARASHTRA
402201
India 
Phone  9822950317  
Fax    
Email  kalikadevakate@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swati Bhagwat 
Designation  HOD and Professor Dept. Of HMM, Y.M.T Homoeopathic College, Kharghar - Navi Mumbai 
Affiliation  Dr. G. D. Pol Foundation, Y. M. T. Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai 
Address  Dr. G. D. Pol Foundation, Y. M. T. Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai

Raigarh
MAHARASHTRA
410210
India 
Phone  9969337242  
Fax    
Email  swati_bhagwat_29@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Swati Bhagwat 
Designation  HOD and Professor Dept. Of HMM, Y.M.T Homoeopathic College, Kharghar - Navi Mumbai 
Affiliation  Dr. G. D. Pol Foundation, Y. M. T. Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai 
Address  Dr. G. D. Pol Foundation, Y. M. T. Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai

Raigarh
MAHARASHTRA
410210
India 
Phone  9969337242  
Fax    
Email  swati_bhagwat_29@yahoo.co.in  
 
Source of Monetary or Material Support  
Dr G D Pol Foundation, Y M T Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai, Institute Of Research Centre Affiliated To MUHS, Nashik 
 
Primary Sponsor  
Name  Dr. Kalika Adhikrao Devakate 
Address  K. E. S. Chandrakant Hari Keluskar Homoeopathic Medical College and Hospital, Khandala - Alibag, Raigad 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kalika Adhikrao Devakate  KESCHKHMC Hospital OPD  KES Chandrakant Hari Keluskar Homoeopathic Medical College and Hospital, Khandala - Alibag, Raigad
Raigarh
MAHARASHTRA 
9822950317

kalikadevakate@gmail.com 
Dr Kalika Devakate  YMT Homoeopathic Medical College OPD  Dr G D Pol Foundation, YMT Homoeopathic Medical College and Hospital, Kharghar - Navi Mumbai
Raigarh
MAHARASHTRA 
9822950317

kalikadevakate@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
YMT Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L430||Hypertrophic lichen planus,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic Medicines  Dose liquid dilution and single or repeated as per case requirement. Frequency from single dose to 1 to 3 times daily based on susceptibility and clinical response. Potency selected according to case parameters i.e cm dm lm. Duration up to 12 months with followup every 15 days or as needed. 
Comparator Agent  Not Applicable  Not Applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Patients above 18 years
2. Male and Female patients of cutaneous lichen planus
3. Patients irrespective of ethnic group, socio economic status and occupation will be included.
4. Clinically pre - diagnosed patients of cutaneous lichen planus.
5.1. Acute eruptive Lichen Planus (EA91.0)
5.2. Hypertrophic Lichen Planus (EA91.1)
5.3. Follicular Lichen Planus (EA91.2)
5.4. Sub acute Lichen Planus (EA91.6) 
 
ExclusionCriteria 
Details  1. Pregnant female and lactating mother
2. Immunocompromised patients.
3. Patients of cutaneous lichen planus who have received any oral or topical medications for cutaneous lichen planus 2 months prior to our treatment.
4.1. Lichen planus of genital skin and mucous membrane (EA91.3)
4.2. Lichen planus and lichenoid reaction of oral mucosa (EA91.4)
4.3. Lichen planus of nail (EA91.5)
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Improved
2. Not Improved 
1. Improved - if LPSI score is less than pre treatment LPSI score
2. Not Improved - if LPSI score is same or more than pre treatment LPSI score 
 
Secondary Outcome  
Outcome  TimePoints 
Assessed as per - Lichen Planus Severity Index A New Valid Scoring System.  Assessed as per - Lichen Planus Severity Index A New Valid Scoring System. 
 
Target Sample Size   Total Sample Size="51"
Sample Size from India="51" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  15/08/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [kalikadevakate@gmail.com].

  6. For how long will this data be available start date provided 25-07-2025 and end date provided 25-07-2028?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Data will be shared upon request via email after de-identification, for academic purposes only.
Brief Summary  

1.Case taking according to standard case report form proforma to form totality with special emphasis on individualizing case.

2. Standard literature and reference books on Homoeopathic Materia Medica, Medicine books, Pathology books, standard Homoeopathic journals, research papers will be considered.

3. Standard software will be used for repertorization of case.

4. Lichen planus severity index a new valid scoring system will be used to assess the severity pre and post treatment. 

 
Close